ILC makes up 10–15% of all invasive breast cancers but often goes underdiagnosed due to its diffuse growth pattern. The hallmark of ILC is the loss of E-cadherin, leading to its characteristic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback